FDA Inspection
TEVA Pharmaceuticals USA, Inc.TEVA Pharmaceuticals USA, Inc. – FDA Inspection, Jul 20, 2026
Record Details
This FDA Inspection record concerns TEVA Pharmaceuticals USA, Inc., with an inspection on July 20, 2026, issued by the New Jersey District Office, covering human drugs.
- Person
View Company Profile
ID · d5e03df0-84ed-480b-bf0b-1df08945fb5a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1311564
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.110(c)In-process materials characteristics testing
Full citation text and observation details available on the Dashboard.
Other FDA inspections of TEVA Pharmaceuticals USA, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 10, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 11, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 1, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 30, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for TEVA Pharmaceuticals USA, Inc.
- FDA Inspection 1191141 - 2022-11-10
- FDA Inspection 1040037 - 2018-01-11
- FDA Inspection 1000179 - 2017-02-01
- FDA Inspection 854234 - 2013-11-06
- FDA Inspection 775065 - 2012-03-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.